'THE GLOBAL CEO INITIATIVE ON ALZHEIMER'S'
WHATThe Global CEO Initiative on Alzheimer's Disease is a partnership initiated by leading global corporations and involving non-profit and governmental organizations.
WHYThe aim is to identify and advance activities necessary to prevent and treat Alzheimer's disease by 2025 and improve the quality of life for all affected by the disease.
WHEREThe Global CEO Initiative on Alzheimer's (CEOi) International.
Program Description
"The Global CEO Initiative on Alzheimer's (CEOi) has been formed to provide business leadership to the fight against Alzheimer's. We intend to lend our voice to the social, fiscal, and political developments on Alzheimer's in order to 'change the game' by adding private-sector partnership and leadership."
-ceoalzheimersinitiative.org
The initiative aims to fight on Alzheimer’s by:
- Spurring innovation and facilitating opportunities to improve the care of those affected by Alzheimer’s.
- Reducing the time, cost and risk of drug development to improve the productivity of R&D investments.
- Accelerating a means of prevention and treatment of Alzheimer’s, including improving the ability to identify and diagnose the disease.
- Spurring new models for care, care preparation and care delivery.
- Re-shaping the environment in which society addresses Alzheimer’s patients and caregivers.
Companies who are helping to fight Alzheimer’s through The Global CEO Initiative on Alzheimer’s include: AC Immune, Bank of America, Banner Health, Eli Lilly, GE Healthcare, Janssen Research and Development (a division of Johnson & Johnson), Merck, Nestle, Pfizer, and Sanofi.
source: ceoalzheimersinitiative.org
Dementia Assistance and Activities
Dementia Training and Dementia Advocacy
WATCH VIDEO ON 'THE GLOBAL CEO INITIATIVE ON ALZHEIMER'S' |
|